RRM2 and neoplasm: Our study identified RRM2 and GAPDH as hypomethylated and upregulated genes in LUAD, suggesting that their hypomethylation leads to increased expression, contributing to enhanced tumor aggressiveness, drug resistance, and poor patient prognosis.